Balancing risks and benefits in the treatment of patients with Bacillus Calmette-Guerin-unresponsive high-risk non-muscle-invasive bladder cancer

Samantha Unsworth-White; Nada Humayun-Zakaria; Richard T. Bryan

doi:10.21037/tau-24-529

Balancing risks and benefits in the treatment of patients with Bacillus Calmette-Guerin-unresponsive high-risk non-muscle-invasive bladder cancer

Samantha Unsworth-White
, Nada Humayun-Zakaria
, Richard T. Bryan^*

^*Corresponding author for this work

Cancer and Genomic Sciences

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English
Pages (from-to)	1-3
Number of pages	3
Journal	Translational Andrology and Urology
Volume	14
Issue number	1
Early online date	16 Jan 2025
DOIs	https://doi.org/10.21037/tau-24-529
Publication status	Published - 31 Jan 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Atezolizumab
circulating-tumour DNA (ctDNA)
non-muscle-invasive bladder cancer (NMIBC)
Bacillus Calmette-Guerin-unresponsive (BCG-unresponsive)
immuno-oncology

Access to Document

10.21037/tau-24-529Licence: Creative Commons: Attribution-NonCommercial-NoDerivs (CC BY-NC-ND)

Cite this

@article{4975435f549a4a13b7e73f548b7fe64c,

title = "Balancing risks and benefits in the treatment of patients with Bacillus Calmette-Guerin-unresponsive high-risk non-muscle-invasive bladder cancer",

keywords = "Atezolizumab, circulating-tumour DNA (ctDNA), non-muscle-invasive bladder cancer (NMIBC), Bacillus Calmette-Guerin-unresponsive (BCG-unresponsive), immuno-oncology",

author = "Samantha Unsworth-White and Nada Humayun-Zakaria and Bryan, \{Richard T.\}",

year = "2025",

month = jan,

day = "31",

doi = "10.21037/tau-24-529",

language = "English",

volume = "14",

pages = "1--3",

journal = "Translational Andrology and Urology",

issn = "2223-4691",

publisher = "AME Publishing Company",

number = "1",

}

TY - JOUR

T1 - Balancing risks and benefits in the treatment of patients with Bacillus Calmette-Guerin-unresponsive high-risk non-muscle-invasive bladder cancer

AU - Unsworth-White, Samantha

AU - Humayun-Zakaria, Nada

AU - Bryan, Richard T.

PY - 2025/1/31

Y1 - 2025/1/31

KW - Atezolizumab

KW - circulating-tumour DNA (ctDNA)

KW - non-muscle-invasive bladder cancer (NMIBC)

KW - Bacillus Calmette-Guerin-unresponsive (BCG-unresponsive)

KW - immuno-oncology

U2 - 10.21037/tau-24-529

DO - 10.21037/tau-24-529

M3 - Comment/debate

C2 - 39974809

SN - 2223-4691

VL - 14

SP - 1

EP - 3

JO - Translational Andrology and Urology

JF - Translational Andrology and Urology

IS - 1

ER -